RT Journal Article
SR Electronic
T1 Digital therapy to improve stuttering symptoms in patients with a deficit of spectral power in the EEG beta frequency band
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.04.21.22272785
DO 10.1101/2022.04.21.22272785
A1 Chernetchenko, Dmytro
A1 Prasolov, Pramax
A1 Aganov, Sam
A1 Voropay, Andrey
A1 Lituiev, Dmytro
A1 Nayshtetik, Eugene
YR 2022
UL http://medrxiv.org/content/early/2022/04/27/2022.04.21.22272785.abstract
AB Background Stuttering is a speech disorder that affects more than 70 million people worldwide, limiting their ability to communicate and socialize. In recent decades, several studies have demonstrated a link between stuttering and a deficit of β electroencephalographic (EEG) power.Aim and Methods This study investigates the efficacy of a novel auditory neuro modulating technology that leverages euphonic music tracks with broad-spectrum binaural beats to induce selective EEG spectral power changes. Adults with stuttering (AWS, n=6) and participants from the control group (n=6) were exposed to euphonic binaural stimuli for 5 minutes. The EEG and electrocardiographic (ECG) bio-signals were recorded prior, during, and after exposure.Results During standard reading tasks without stimulation, β-power in the left hemisphere in the adults without stuttering and with stuttering differed. The left-right hemisphere asymmetry in β-wave power was observed in the control group but not in AWS. After the stimulation, the power of β-band in AWS participants in the left hemisphere increased 1.54-fold, while changes in the right hemisphere activity were not significant. Average β-band power within left frontotemporal area and temporoparietal junction after stimulation in AWS participants shows an increase of β-band in left frontotemporal junction by 1.65-fold and in left temporoparietal by 1.72-fold. The changes in the quality of speech were assessed based on the speech rate and the rate of speech disfluencies evaluated by speech therapists. The rate of disfluencies dropped significantly after the stimulation (median 74.70% of the baseline rate), but the effect was not significantly different from the baseline 10 min later (median 65.51% of the baseline rate). Similarly, the speech rate significantly increased immediately after the stimulation (median 133.15%) but was not significantly different 10 min later (median 126.63% of the baseline rate). In this study, we found significant correlations of β-activation level in left temporoparietal projection (Spearman ρ=-0.54,) and left frontotemporal area (Spearman ρ=-0.58) with disfluency rate of speech.Conclusions We show for the first time that auditory binaural beats stimulation can substantially improve speech fluency in AWS and its effect is related to boost of EEG β-band power in speech-production centers. The changes in β power are detected immediately after the exposure and persist 10 min later. Additionally, these effects are accompanied by a reduction in stress level as monitored by ECG markers. This suggests that auditory binaural beats stimulation temporarily improves speech quality in AWS by increasing β-band power of EEG in speech centers of the brain.Competing Interest StatementThe authors declare the existence of the following commercial interests: - The authors of this paper represent one organization (SynthezAI Corp, San Francisco, California, U.S.A) that funds the following research. - Obtaining commercial benefits from the used results of previously provided clinical trials NCT03532152: "Study of the Effect of the VR Technology on Recovery of the Autonomic Nervous System in Volunteers Affected by Stress". (https://clinicaltrials.gov/ct2/show/NCT03532152), Pure Purr LLC. - Obtaining commercial benefits related to the development of similar products based on the different AI applications, Nebeskey Inc. - Obtaining commercial benefits related to the development of the product (ZOV.ai) as an outcome of the current work; - United Kingdom Patent Application No. 2116927.1 Clinical TrialNCT05339906Funding StatementThis study did not receive any funding (private funds of manuscript authors)Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics Committees of Oles Honchar Dnipro National University gave ethical approval for this workI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present work are contained in the manuscript https://drive.google.com/drive/folders/1h3Jg7hcAV5WNuRwLAHfTrzqOmTMIQLfS?usp=sharing